MARKET

OXFD

OXFD

Oxford Immunotec
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.97
0.00
0.00%
After Hours: 21.97 0 0.00% 16:00 03/03 EST
OPEN
22.00
PREV CLOSE
21.97
HIGH
22.00
LOW
21.96
VOLUME
898.82K
TURNOVER
--
52 WEEK HIGH
23.11
52 WEEK LOW
8.37
MARKET CAP
561.95M
P/E (TTM)
-34.3603
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
8-K: Oxford Immunotec Global PLC
falseX00001586049NASDAQ00015860492021-02-262021-02-26 -------------------------------------------------------------------------------- UNITED STATES...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 4d ago
Oxford Immunotec Has Returned 62.6% Since SmarTrend Recommendation (OXFD)
Feb 25, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Oxford Immunotec (NASDAQ:OXFD) on November 5th, 2020 at $13.49. In...
marketwatch.com · 6d ago
Tuberculosis Diagnostics Market Growth Survey 2021 with Top Countries Data Industry Size, Share, Business Growth, Revenue, Trends, Market Demand Penetration and Forecast | With Covid 19 Analysis
The Express Wire · 02/24 02:49
Oxford Immunotec (OXFD) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Zacks.com · 02/22 17:30
Lyme Disease Diagnostic Devices Market is Exhibiting a CAGR of 7.2% By 2027
Feb 22, 2021 (Market Insight Reports) -- The Lyme Disease Diagnostic Devices Market size is forecast to exceed US$ 3.87 billion by 2027 and is projected to...
Market Insight Reports · 02/22 05:35
Oxford Immunotec Has Returned 62.7% Since SmarTrend Recommendation (OXFD)
Feb 18, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Oxford Immunotec (NASDAQ:OXFD) on November 5th, 2020 at $13.49. In...
marketwatch.com · 02/18 05:32
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - RP, CUB, CRHM, OXFD, FLIR, CBLI, AJRD
, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
PR Newswire - PRF · 02/17 18:22
Shares of OXFD Up 63.0% Since Uptrend Call on Shares
SmarTrend identified an Uptrend for Oxford Immunotec (NASDAQ:OXFD) on November 5th, 2020 at $13.49. In approximately 3 months, Oxford Immunotec has returned 63.00% as of today's recent price of $21.98.
Comtex SmarTrend(R) · 02/10 17:56
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OXFD. Analyze the recent business situations of Oxford Immunotec through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OXFD stock price target is 22.50 with a high estimate of 25.00 and a low estimate of 21.00.
EPS
Institutional Holdings
Institutions: 124
Institutional Holdings: 30.68M
% Owned: 119.93%
Shares Outstanding: 25.58M
TypeInstitutionsShares
Increased
21
1.74M
New
14
1.87M
Decreased
28
2.03M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-2.96%
Healthcare Equipment & Supplies
-2.63%
Key Executives
Chairman/Independent Director
Patrick Balthrop
Chief Executive Officer/Director
Peter Wrighton-Smith
Chief Financial Officer
Matthew McLaughlin
General Counsel/Secretary
Janet Kidd
Independent Director
Ronald Andrews
Independent Director
Mark Klausner
Independent Director
Patricia Randall
Independent Director
Herman Rosenman
Independent Director
Richard Sandberg
Independent Director
James Tobin
Independent Director
Andrew Walton
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About OXFD
Oxford Immunotec Global PLC,is a diagnostics company. It is focused on developing and commercializing tests for under-served immune-regulated conditions. Its product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. It offers a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Tick-borne disease is the collective name for diseases passed to humans through the bite of an infected tick. Its diagnostic tests for tick-borne infections include multiple laboratory developed tests (LDTs). Its tick-borne disease tests utilize molecular methods (such as polymerase chain reaction) and techniques to prosecute the immune system. It has a series of assays for use in blood screening, building upon its expertise in tick-borne disease.

Webull offers kinds of Oxford Immunotec Global PLC stock information, including NASDAQ:OXFD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OXFD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OXFD stock methods without spending real money on the virtual paper trading platform.